PlusCBD™ Oil Roll-On establish at 945 Kroger Stores in 17 U.S. States
LAS VEGAS, NEVADA, June 12, 2019 (WORLD NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a supplier that is preeminent maker of hemp CBD items, is pleased to announce further expansion of its industry-dominating PlusCBD™ Oil cbdoildelivery.org brand because of the Kroger Co. (NYSE:KR).
The Company’s expanded retail circulation includes the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across a lot of its retail banners, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths places in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and further Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant components, warming camphor and cooling menthol. Made out of its Gold Formula concentrated complete range hemp extract, the Roll-Ons offer high intensity help within an easy-to-use application. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms are also available at the participating Kroger places. All PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and are made without artificial dyes or scents to meet consumer expectations of clean ingredients.
As talked about from the Company’s very first quarter 2019 profits turn to May 8, 2019, CV Sciences’ recent distribution gains consist of accessibility to PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy shops. By adding 945 Kroger places and brand new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are obtainable in 4,591 stores, up from 3,308 shops as of March 31, 2019, a rise of 38.7% on the previous 8 weeks.
“We are pleased to partner with Kroger and introduce our Roll-On that is new topical we carry on our quick expansion to the FDM channel,” said Joseph Dowling, ceo. “Kroger, CVS Pharmacy, and other leading national retailers are keenly alert to the increased consumer need for hemp-based CBD products and are partnering with CV Sciences due to our commitment that is unwavering to and quality. Our company is at the start of that which we think are going to be broad acceptance of CBD products across national FDM reports and we also enjoy our continued growth even as we expand shop count and SKUs with this retail partners.”
PlusCBD™ Oil Extra Strength Balm ranks number 1 in product product sales both in the Total U.S. Natural Channel and complete U.S. MULO (Multi Outlet) over the last 52 days* among CBD products within Topical Analgesics, based on SPINS and IRI information, correspondingly. Brightfield Group, a respected predictive analytics and general market trends company when it comes to CBD market, expects $1.3 billion in product sales of CBD topicals in 2019, by having a compound growth that is annual of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) runs two business that is distinct: a customer item division centered on production, marketing and attempting to sell plant-based CBD items to a selection of market sectors; and a medication development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil may be the top-selling make of hemp-derived CBD in the marketplace, relating to SPINS, the key provider of syndicated data and insights when it comes to normal, natural and specialty services and products industry. CV Sciences, Inc. has offices that are primary facilities in north park, California and nevada, Nevada. Extra information can be obtained from OTCMarkets.com or by visiting www.cvsciences.com.
This pr release may include specific forward-looking statements and information, as defined inside the meaning of Section 27A for the Securities Act of 1933 and Section 21E associated with the Securities Exchange Act of 1934, and it is at the mercy of the Safe Harbor developed by those parts. This product contains statements about expected future occasions and/or economic outcomes which are forward-looking in general and susceptible to dangers and uncertainties. Such forward-looking statements by meaning incorporate risks, uncertainties.